[Secondary cardiovascular prevention after acute coronary syndrome in clinical practice].
Secondary prevention after acute coronary syndromes should be aimed at reducing the risk of further adverse cardiovascular events, thereby improving quality of life, and lengthening survival. Despite compelling evidence from large randomized controlled trials, secondary prevention is not fully implemented in most cases after hospitalization for acute coronary syndrome. The Lazio Region (Italy) has about 5.3 million inhabitants (9% of the entire Italian population). Every year about 11 000 patients are admitted for acute coronary syndrome in hospitals of the Lazio Region. Most of these patients receive state-of-the art acute medical and interventional care during hospitalization. However, observational data suggest that after discharge acute coronary syndrome patients are neither properly followed nor receive all evidence-based treatments. This consensus document has been developed by 11 Scientific Societies of Cardiovascular and Internal Medicine in order develop a sustainable and effective clinical approach for secondary cardiovascular prevention after acute coronary syndrome in the local scenario of the Lazio Region. An evidence-based simplified decalogue for secondary cardiovascular prevention is proposed as the cornerstone of clinical intervention, taking into account regional laws and relative shortage of resources. The following appropriate interventions should be consistently applied: smoking cessation, blood pressure control (blood pressure < 130/80 mmHg), optimal lipid management (LDL cholesterol < 80 mmHg), weight and diabetes management, promotion of physical activity and rehabilitation, correct use of antiplatelet agents, beta-blockers, renin-angiotensin-aldosterone system blockers.
Colivicchi
Furio
F
ANMCO (Associazione Nazionale Medici Cardiologi Ospedalieri) Sezione Lazio. f.colivicchi@sanfilipponeri.roma.it
Di Roma
Angelo
A
Uguccioni
Massimo
M
Scotti
Emilio
E
Ammirati
Fabrizio
F
Arcas
Marcello
M
Avallone
Aniello
A
Bonaccorso
Orazio
O
Germanò
Giuseppe
G
Letizia
Claudio
C
Manfellotto
Dario
D
Minardi
Giovanni
G
Pristipino
Christian
C
D'Amore
Francesco
F
Di Veroli
Claudio
C
Fierro
Aldo
A
Pastorellio
Ruggero
R
Tozzi
Quinto
Q
Tubaro
Marco
M
Santini
Massimo
M
Angelico
Francesco
F
Azzolini
Paolo
P
Bellasi
Antonio
A
Brocco
Paola
P
Calò
Leonardo
L
Cerquetani
Elena
E
De Biase
Luciano
L
Di Napoli
Mauro
M
Galati
Alfonso
A
Gallieni
Maurizio
M
Jesi
Anna Patrizia
AP
Lombardo
Antonella
A
Loricchio
Vincenzo
V
Menghini
Fabio
F
Mezzanotte
Roberto
R
Minutolos
Roberto
R
Mocini
David
D
Patti
Giuseppe
G
Patrizi
Roberto
R
Pajes
Giuseppe
G
Pulignano
Giovanni
G
Ricci
Renato Pietro
RP
Ricci
Roberto
R
Sardella
Gennaro
G
Strano
Stefano
S
Terracina
David
D
Testa
Marco
M
Tomai
Fabrizio
F
Volpes
Roberto
R
Volterrani
Maurizio
M
D054058:Acute Coronary Syndrome / Q000150:complications* / Q000453:epidemiology / Q000534:rehabilitation; D000428:Alcohol Drinking; D000465:Algorithms; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003645:Death, Sudden / Q000209:etiology / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000628:therapy; D050171:Dyslipidemias / Q000517:prevention & control; D005247:Feeding Behavior; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D007558:Italy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D055502:Secondary Prevention
D010975:Platelet Aggregation Inhibitors